Moreover, EHD1 has been associated with cell proliferation, apoptosis, metastasis, and drug resistance in breast and non-small cell lung cancer (NSCLC) [25] but has not been reported to be abnormal in malignant mesotheliomas. This evidence concerns the gene EHD1 and non-small cell lung carcinoma.